ПРАКТИЧЕСКИЕ РЕКОМЕНДАЦИИ
В связи с высокой частотой выявления нестабильных атеросклеротических бляшек в коронарных артериях использование ВСУЗИ со спектральным анализом радиочастотных данных может служить важным дополнительным методом оценки состояния коронарного русла при недостаточной информативности традиционной рентгенконтрастной ангиографии. Оценка прогностической значимости состава атеросклеротических бляшек по данным ВСУЗИ с виртуальной гистологией требует проведения дальнейших исследований.
Определение концентрации апобелка В100 и матриксных металлопротеиназ 7 и 9 типа может быть использовано в качестве дополнительных факторов, ассоциирующихся с наличием нестабильных атеросклеротических бляшек, и служить основанием для проведения более активной медикаментозной терапии, направленной на снижение риска сердечно-сосудистых осложнений.
Список литературы
Алмазов В.А., Атьков О.Ю., Беленков Ю.Н.; под ред. Чазова Е.И. Болезни органов кровообращения. Москва: Медицина, 1997.
Бабунашвили А.М., Иванов В.А., Бирюков С.А. Эндопротезирование (стентирование) венечных артерий сердца. – Москва: АСВ, 2001.
Заболеваемость взрослого населения России в 2011 году. Статистические материалы, Москва, 2012, Здравоохранение в России 2011. Статистический сборник, Москва, 2011.
Иваницкий А.В., Алекян Б.Г., Крюков В.А. и др. Значение внутрисосудистого ультразвукового исследования в оценке состояния просвета и стенки сосудов при интервенционных радиологических процедурах. Вестн рентгенол. 1996; 5: 26-34.
Кухарчук В.В., Сусеков А.В., Зубарева М.Ю. и др. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации IV пересмотр. ВНОК, Москва. 2009.
Померанцев Е.В., Воронин В.А., Давыдов С.А. и.др. Первый опыт клинического применения внутрисосудистого ультразвукового сканирования в общей ангиографии. Терапевтический архив. 1992;.12: 10-17.
Abizaid A.S., Mintz G.S., Pichard A.D., et al. Clinical, intravascular ultrasound, and quantitative angiographic determinants of the coronary flow reserve before and after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1998; 82: 423-428.
Abizaid A.S., Mintz G.S., Abizaid A., et al. One-year follow-up after intravascular ultrasound assessment of moderate left main coronary artery disease in patients with ambiguous angiograms. J Am Coll Cardiol. 1999; 34(3): 707–715.
Abizaid A.S., Mintz G.S., Mehran R., et al. Long-term follow-up after percutaneous transluminal coronary angioplasty was not performed based on intravascular ultrasound findings: importance of lumen dimensions. Circulation. 1999; 100(3): 256–261.
Allen S., Khan S., Tam S.P., et al. Expression of adhesion molecules by Lp(a): a potential novel mechanism for its atherogenicity. FASEB Journal. 1998; 12(15): 1765–1776.
Armstrong E.J., Morrow D.A., Sabatine M.S., et al. Inflammatory biomarkers in acute coronary syndromes: part II: acute-phase reactants and biomarkers of endothelial cell activation. Circulation. 2006; 21: 113-117.
Armstrong E.J., Morrow D.A., Sabatine M.S., et al. Inflammatory biomarkers in acute coronary syndromes: part IV: matrix metalloproteinases and biomarkers of platelet activation. Circulation. 2006; 7: 113-119.
Batkoff B., Linker D. Safety of intracoronary ultrasound: Data from a multicenter European registry. Cathet Cardiovasc Diagn. 1996; 38: 238–241.
Blankenberg S., Rupprecht H.J., Poirier O., et al. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 2003; 107: 1579 – 1585.
Bom N., Lancée C.T., Van Egmond F.C. An ultrasonic intracardiac scanner. Ultrasonics. 1972; 10(2): 72-76.
Briguori C., Anzuini A., Airoldi F., et al. Intravascular ultrasound criteria for the assessment of the functional significance of intermediate coronary artery stenoses and comparison with fractional flow reserve. Am J Cardiol. 2001; 87(2): 136–141.
Burke A.P., Farb A., Malcom G.T., et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997; 336: 1276-1282.
Burke A.P., Farb A., Malcom G.T., et al. Plaque rupture and sudden death related to exertion in men with coronary artery disease. JAMA. 1999; 281(10): 921-926.
Burke A.P., Tracy R.P., Kolodgie F., et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation. 2002; 105: 2019-2023.
Carlier S.G., Mintz G.S., Stone G.W. Imaging of atherosclerotic plaque using radiofrequency ultrasound signal processing. J Nucl Cardiol. 2006; 13: 831–840.
Chapman M.J., Huby T., Nigon F., et al. Lipoprotein (a): implication in atherothrombosis. Atherosclerosis.1994; 110: 69–75.
Cicero A.F., Gaddi A. REVERSAL and PROVE-IT: are clinically oriented trials really better than "pure" scientific studies? Int J Cardiol. 2005; 103(3): 235-237.
Cieszynski T. Intracardiac method for the investigation of structure of the heart with the aid of ultrasonics. Arch Immunol Ther Exp. 1960; 8: 551-557.
Cooper J.A., Miller G.J., Humphries S.E. A comparison of the PROCAM and Framingham point-scoring systems for estimation of individual risk of coronary heart disease in the Second Northwick Park Heart Study. Atherosclerosis. 2005; 181: 93-100.
Courtney B.K., Fitzgerald P.J. Intravascular ultrasound and tissue characterization. Handbook of the vulnerable plaque. Taylor & Francis, New York and London, 2004. 219-236
Craig W.Y., Neveux L.M., Palomaki G.E., et al. Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies. Clinical Chemistry. 1998; 44(11): 2301–2306.
Crowley R.J., Hamm M.A., Joshi S.H., et al. Ultrasound guided therapeutic catheters: recent developments and clinical results. Int J Card Imaging. 1991; 6(3-4): 145-56.
Danesh J., Collins R., Peto R. Lipoprotein(a) and coronary heart disease: meta-analysis of prospective studies. Circulation. 2000; 102(10): 1082–1085.
De Rijke Y.B., Jurgens G., Hessels E., et al. In vivo fate and scavenger receptor recognition of oxidized lipoprotein(a) isoforms in rats. Journal of Lipid Research. 1992; 33(9): 1315–1325.
Di Mario C., Görge G., Peters R., et al. Clinical application and image interpretation in intracoronary ultrasound. Study Group on Intracoronary Imaging of the Working Group of Coronary Circulation and of the Subgroup on Intravascular Ultrasound of the Working Group of Echocardiography of the European Society of Cardiology. Eur Heart J. 1998; 19(2): 207–229.
Eckart R., Uyehara C., Sry E., et al. Matrix metalloproteinases in patients with myocardial infarction and percutaneous revascularization. J Interv Cardiol. 2004; 17: 27–31.
Farb A., Burke A.P., Tang A.L., et al. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996; 93(7): 1354-1363.
Fassa A.A., Wagatsuma K., Higano S.T., et al. Intravascular ultrasound-guided treatment for angiographically indeterminate left main coronary artery disease: a long-term follow-up study. J Am Coll Cardiol. 2005; 45(2): 204-211.
Fless G.M., Rolih C.A., Scanu A.M. Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins. Journal of Biological Chemistry. 1984; 259(18): 11470–11478.
Fox K., Garcia M.A., Ardissino D. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J. 2006; 27: 1341-1381.
Fukuda D., Shimada K., Tanaka A., et al. Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. Am J Cardiol. 2006; 97(2): 175-80.
Galis Z.S., Khatri J.J. Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly. Circ Res. 2002; 90: 251 – 262.
Galvano F., Li G., Volti M., et al. Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy, vol. 10, no. 12, pp. 1875–1882, 2009.
Galvano F., Malaguarnera M., Vacante M., et al. Physiopathology of lipoprotein (a). Frontiers in Bioscience. 2010; 2: 866–875.
Garcia-Garcia H.M., Goedhart D., Schuurbiers J.C., et al. Virtual histology and remodeling index allow in vivo identification of allegedly high-risk coronary plaques in patients with acute coronary syndromes: a three vessel intravascular ultrasound radiofrequency data analysis. EuroIntervention. 2006; 2: 338-344.
Gaw A., Murray H.M., Brown E.A., Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER). Atherosclerosis. 2005; 180(2): 381–388.
Gorge G. Intravascular ultrasound: Safety and indications for use in 7085 consecutive patients studied in 32 centers in Europe and Israel. J Am Coll Cardiol. 1996; 27: 155.
Guédès A., Keller P.F., L'Allier P.L., et al. Long-term safety of intravascular ultrasound in nontransplant, nonintervened, atherosclerotic coronary arteries. J Am Coll Cardiol. 2005; 45(4): 559–564.
Gussenhoven E.J., Essed C.E., Lancée C.T., et al. Arterial wall characteristics determined by intravascular ultrasound imaging: an in vitro study. J Am Coll Cardiol. 1989; 14(4): 947-952.
Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352(16): 1685-1695.
Haque N.S., Zhang X., French D., et al. CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells. Circulation. 2000; 102(7): 786–792.
Hartmann M., von Birgelen C., Mintz G.S., et al. Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries. J Am Coll Cardiol. 2006; 48(3): 446-452.
Hausmann D., Erbel R., Alibelli-Chemarin M.J., et al. The safety of intracoronary ultrasound. A multicenter survey of 2207 examinations. Circulation. 1995; 91: 623–630.
Heinrich J., Schulte H., Schonfeld R., et al. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost. 1995; 73: 374 – 378.
Hodgson J.M., Graham S.P., Savakus A.D., et al. Clinical percutaneous imaging of coronary anatomy using an over-the-wire ultrasound catheter system. Int J Card Imaging. 1989; 4(2-4): 187-193.
Hong M.K., Mintz G.S., Lee C.W., et al. Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: a three-vessel intravascular ultrasound study in 235 patients. Circulation. 2004; 110(8): 928-933.
Igarashi Y., Aizawa Y., Satoh T., et al. Predictors of adverse long-term outcome in acute myocardial infarction patients undergoing primary percutaneous transluminal coronary angioplasty with special reference to the admission concentration of lipoprotein (a). Circulation. 2003; 67(7): 605–611.
Imhof A., Rothenbacher D,. Khuseyinova N., et al. Plasma lipoprotein Lp(a), markers of haemostasis and inlammation, and risk and severity of coronary heart disease. Eur J of Cardiovasc Prev and Rehab. 2003; 10(5): 362–370.
Inokubo Y., Hanada H., Ishizaka H., et al. Plasma levels of matrix metalloproteinase-9 and tissue-inhibitor of metalloproteinase-1 are increased in the coronary circulation of patients with acute coronary syndrome. Am Heart J. 2001; 141: 211–217.
Jang I.K., Tearney G.J., MacNeill B., et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation. 2005; 111(12): 1551-1555.
Jasti V., Ivan E., Yalamanchili V., et al. Correlations between fractional flow reserve and intravascular ultrasound in patients with an ambiguous left main coronary artery stenosis. Circulation. 2004; 110(18): 2831–2836.
Jialal I., Devaraj S., Singh U. C-reactive protein and the vascular endothelium: implications for plaque instability. J Am Coll Cardiol. 2006; 47(7): 1379-1381.
Joseph A., Ackermann D., Talley J.D., et al. Manifestations of coronary atherosclerosis in young trauma victims: an autopsy study. J Am Coll Cardiol. 1993; 22: 459–467.
Kai H., Ikeda H., Yasukawa H., et al. Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol. 1998; 32: 368-372.
Kamstrup P.R., Benn M., Tybjærg-Hansen A., et al. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Circulation. 2008; 117(2): 176–184.
Kawaguchi R., Oshima S., Jingu M., et al. Usefulness of virtual histology intravascular ultrasound to predict distal embolization for ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2007; 50: 1641-1646.
Kawamoto T., Okura H., Koyama Y., et al. The relationship between coronary plaque characteristics and small embolic particles during coronary stent implantation. J Am Coll Cardiol. 2007; 50: 1635-1640.
Kawasaki M., Sano K., Okubo M., et al. Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. J Am Coll Cardiol 2005; 45: 1946-1953.
Ko Y.G., Le V.C., Kim B.H., et al. Correlations between coronary plaque tissue composition assessed by virtual histology and blood levels of biomarkers for coronary artery disease. Yonsei Med J. 2012; 53(3): 508-516.
Kolodgie FD, Virmani R, Burke AP, et al. Pathologic assessment of the vulnerable human coronary plaque. Heart. 2004. Vol. 90. P. 1385–1391.
König A., Klauss V. Virtual histology. Heart. 2007; 93(8): 977-982.
Kostner K.M., Maurer G., Huber K., et al. Urinary excretion of apo(a) fragments: role in apo(a) catabolism. Arter tromb and Vasc Biol. 1996; 16(8): 905–911.
Kostner K.M., Oberbauer R., Hoffmann U., et al. Urinary excretion of apo(a) in patients afer kidney transplantation. Nephr DialTranspl. 1997; 12(12): 2673–2678.
Kragel A.H., Reddy S.G., Wittes J.T., et al. Morphometric analysis of the composition of atherosclerotic plaques in the four major epicedial coronary arteries in acute myocardial infarction and in sudden coronary death. Circulation. 1989; 80: 1747–1756.
Kragel A.H., Reddy S.G., Wittes J.T., et al. Morphometric analysis of the composition of coronary arterial plaques in isolated unstable angina pectoris with pain at rest. Am J Cardiol. 1990; 66: 562–567.
Kubo T., Matsuo Y., Hayashi Y., et al. High-sensitivity C-reactive protein and plaque composition in patients with stable angina pectoris: a virtual histology intravascular ultrasound study. Coron Artery Dis. 2009; 20(8): 531-535.
Lagrand W.K., Visser C.A., Hermens W.T., et al. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon? Circulation. 1999; 100: 96 – 102.
Lawn R.M., Wade D.P., Hammer R.E., et al. Atherogenesis in transgenic mice expressing human apolipoprotein(a). Nature. 1992; 360(6405). 670–672.
Libby P., Geng Y.J., Aikawa M., et al. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol. 1996; 7(5): 330-335.
|
